Literature DB >> 25948474

Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity.

V V Nenasheva1, G V Kovaleva, L V Uryvaev, K S Ionova, A V Dedova, G K Vorkunova, S V Chernyshenko, N V Khaidarova, V Z Tarantul.   

Abstract

In the present research, we have studied an influence of enhanced expression TRIM14 on alphavirus Sindbis (SINV, Togaviridae family) infection. In the HEK293 cells transfected with human trim14 gene (HEK-trim14), SINV yield after infection was decreased 1000-10,000 times (3-4 lg of TCD50/ml) at 24 h p.i. and considerably less (1-2 lg of TCD50/ml) at 48 h p.i. Analysis of the expression of 43 genes directly or indirectly involved in innate immune machine in HEK-trim14 non-infected cells comparing with the control (non-transfected) HEK293 cells revealed that stable trim14 transfection in HEK293 cells caused increased transcription of 18 genes (ifna, il6 (ifnβ2), isg15, raf-1, NF-kB (nf-kb1, rela, nf-kb2, relb), grb2, grb3-3, traf3ip2, junB, c-myb, pu.1, akt1, tyk2, erk2, mek2) and lowered transcription of 3 genes (ifnγ, gata1, il-17a). The similar patterns of genes expression observe in SINV-infected non-transfected HEK293 cells. However, SINV infection of HEK-trim14 cells caused inhibition of the most interferon cascade genes as well as subunits of transcription factor NF-κB. Thus, stable enhanced expression of trim14 gene in cells activates the transcription of many immunity genes and suppresses the SINV reproduction, but SINV infection of HEK-trim14 cells promotes inhibition of some genes involved in innate immune system.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948474     DOI: 10.1007/s12026-015-8653-1

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  40 in total

Review 1.  Second nature: biological functions of the Raf-1 "kinase".

Authors:  Manuela Baccarini
Journal:  FEBS Lett       Date:  2005-03-23       Impact factor: 4.124

2.  TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection.

Authors:  Jie Wang; Baoming Liu; Nan Wang; Young-Min Lee; Chunming Liu; Kui Li
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo.

Authors:  Deborah J Lenschow; Nadia V Giannakopoulos; Lacey J Gunn; Christine Johnston; Andy K O'Guin; Robert E Schmidt; Beth Levine; Herbert W Virgin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene.

Authors:  M Rehli; A Poltorak; L Schwarzfischer; S W Krause; R Andreesen; B Beutler
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

Review 5.  Control of viral infectivity by tripartite motif proteins.

Authors:  Greg J Towers
Journal:  Hum Gene Ther       Date:  2005-10       Impact factor: 5.695

6.  Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.

Authors:  C W Czarniecki; P T Allen
Journal:  Antiviral Res       Date:  1984-12       Impact factor: 5.970

7.  Interferon induction by viruses. II. Sindbis virus: interferon induction requires one-quarter of the genome--genes G and A.

Authors:  P I Marcus; F J Fuller
Journal:  J Gen Virol       Date:  1979-07       Impact factor: 3.891

8.  PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.

Authors:  N Bonadies; Ch Neururer; A Steege; S Vallabhapurapu; T Pabst; B U Mueller
Journal:  Oncogene       Date:  2009-12-07       Impact factor: 9.867

9.  Genomic analysis of the host response to hepatitis C virus infection.

Authors:  Andrew I Su; John P Pezacki; Lisa Wodicka; Amy D Brideau; Lubica Supekova; Robert Thimme; Stefan Wieland; Jens Bukh; Robert H Purcell; Peter G Schultz; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

10.  TRIM E3 ligases interfere with early and late stages of the retroviral life cycle.

Authors:  Pradeep D Uchil; Brian D Quinlan; Wai-Tsing Chan; Joseph M Luna; Walther Mothes
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  15 in total

1.  Positive selection of the TRIM family regulatory region in primate genomes.

Authors:  Dan-Dan He; Yueer Lu; Rachel Gittelman; Yabin Jin; Fei Ling; Akey Joshua
Journal:  Proc Biol Sci       Date:  2016-10-12       Impact factor: 5.349

2.  Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.

Authors:  Hannah Carter; Rachel Marty; Matan Hofree; Andrew M Gross; James Jensen; Kathleen M Fisch; Xingyu Wu; Christopher DeBoever; Eric L Van Nostrand; Yan Song; Emily Wheeler; Jason F Kreisberg; Scott M Lippman; Gene W Yeo; J Silvio Gutkind; Trey Ideker
Journal:  Cancer Discov       Date:  2017-02-10       Impact factor: 39.397

3.  Proteolytic cleavage of host proteins by the Group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus.

Authors:  Elaine M Morazzani; Jaimee R Compton; Dagmar H Leary; Angela V Berry; Xin Hu; Juan J Marugan; Pamela J Glass; Patricia M Legler
Journal:  Antiviral Res       Date:  2019-02-10       Impact factor: 10.103

4.  Expression of the human TRIM14 and its mutant form (P207L) promotes apoptosis in transgenic loaches.

Authors:  Valentina V Nenasheva; Ekaterina A Stepanenko; Irina V Makarova; Nella V Khaidarova; Stanislav A Antonov; Larisa V Kozikova; Ekaterina A Polteva; Galina V Kovaleva; Zeineb Ayed; Anastasia D Vovk; Natalya A Shcherbatova; Lyudmila E Andreeva; Vyacheslav Z Tarantul
Journal:  Mol Biol Rep       Date:  2018-09-10       Impact factor: 2.316

5.  Human TRIM14 protects transgenic mice from influenza A viral infection without activation of other innate immunity pathways.

Authors:  Valentina V Nenasheva; Natalia A Nikitenko; Ekaterina A Stepanenko; Irina V Makarova; Lyudmila E Andreeva; Galina V Kovaleva; Andrey A Lysenko; Amir I Tukhvatulin; Denis Y Logunov; Vyacheslav Z Tarantul
Journal:  Genes Immun       Date:  2021-04-16       Impact factor: 2.676

6.  TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.

Authors:  Josephine Hai; Chang-Qi Zhu; Tao Wang; Shawna L Organ; Frances A Shepherd; Ming-Sound Tsao
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

7.  Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway.

Authors:  Yi-Jiong Li; Guo-Ping Zhang; Feng Zhao; Rui-Qi Li; Shao-Jun Liu; Zeng-Ren Zhao; Xin Wang
Journal:  Exp Ther Med       Date:  2017-12-27       Impact factor: 2.447

8.  miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.

Authors:  Tong Wang; Yipeng Ren; Ruixun Liu; Juntao Ma; Yueyi Shi; Lei Zhang; Rongfa Bu
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

9.  Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.

Authors:  Xuan Su; Jianning Wang; Weichao Chen; Zhaoqu Li; Xiaoyan Fu; Ankui Yang
Journal:  Oncotarget       Date:  2016-03-01

10.  TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein.

Authors:  Shanshan Wang; Yongzhi Chen; Chunfeng Li; Yaoxing Wu; Lei Guo; Changwei Peng; Yueping Huang; Genhong Cheng; F Xiao-Feng Qin
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.